HB 179 modifies Tennessee's criminal abortion law by adding exceptions that exempt certain abortions from criminal prosecution. It specifies that performing an abortion is not a crime if it is necessary to protect the pregnant person's physical or mental health, or if the pregnancy resulted from rape or incest (as defined in Tennessee law). The bill amends Title 39, Chapter 15 of Tennessee Code, reclassifying such abortions as non-criminal under these specific circumstances. This change takes effect July 1, 2025, directly affecting licensed physicians performing abortions and pregnant individuals in these defined situations.
SB 231 requires Tennessee health insurance plans to cover speech therapy specifically for stuttering, including both habilitative (helping learn or improve communication skills) and rehabilitative (helping restore lost skills) services. The law prohibits annual visit limits, prior authorization, restrictions based on the cause of stuttering, and excludes utilization review for these services, while mandating coverage for both in-person and telehealth options. This requirement applies to health benefit plans renewing or issuing policies on or after July 1, 2025. The bill directly affects insured individuals seeking speech therapy for stuttering and insurers offering health coverage in Tennessee.
SB 440 clarifies that standalone dental and vision insurance plans (known as "excepted benefits") are not required to cover specific medical treatments, services, or conditions unless state law explicitly mandates it. This change directly affects health insurance plans offering these stand-alone benefits, removing an implied obligation to cover certain medical needs under those plans. The law applies to all new or renewed insurance policies issued on or after July 1, 2025, ensuring clarity for insurers and policyholders. It does not alter existing coverage requirements for standard health insurance plans.
HB 1198 requires Tennessee health insurers and TennCare to allow patients to try biosimilar drugs (cost-effective copies of brand-name medications) before covering the original branded drug. It amends state law to permit health carriers to mandate a biosimilar trial for equivalent branded prescriptions, removing prior requirements for generic drug trials. The bill also directs TennCare’s pharmacy committee to consider biosimilar drugs when recommending medications for the state’s preferred drug list. These changes aim to reduce prescription drug costs by increasing biosimilar adoption, as stated in the bill’s legislative findings.
HB 584 extends the expiration date of Tennessee's annual limit on new nursing home beds from June 30, 2025, to June 30, 2029. The bill maintains the current cap of 125 new nursing home beds per fiscal year that the Health Facilities Commission can approve through its certificate of need process. This change directly affects nursing home operators seeking to expand their facilities and the commission responsible for reviewing such requests. The bill does not alter the 125-bed limit but only extends the period during which it remains in effect.
HB 395, the "Tennessee Genomic Security and End Organ Harvesting Act," prohibits Tennessee health insurers from covering organ transplants or post-transplant care if the organ was sourced from China or procured through sale/donation originating in China. It also bans medical and research facilities from using genetic sequencing equipment or software produced by entities linked to "foreign adversaries" (specifically targeting China per the bill's context), requiring replacement within 180 days. Additionally, the bill mandates that all genetic sequencing data must be stored within the United States, with remote access from outside the country prohibited without approval from the state health commissioner. The law takes effect on January 1, 2026, directly affecting health insurers, hospitals, and research facilities operating in Tennessee.
